STOCK TITAN

Brown & Brown (BRO) Financials

BRO NYSE
Trailing 12 months to September 30, 2026
Revenue $6.9B +26.1% YoY
Net Income $1.2B +22.1% YoY
EPS (Diluted) $3.16 -5.4% YoY
Free Cash Flow $1.5B +14.5% YoY
Market Cap $24.2B as of Nov 20, 2026
Price / Sales 3.5x on $6.9B revenue, trailing 12 months to September 30, 2026
Price / Earnings 19.9x on $1.2B net income, trailing 12 months to September 30, 2026
Price / Book 1.9x on $12.6B equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 20, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q3 FY2026, filed Oct 26, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BRO SEC filings page.

Brown & Brown, Inc. (BRO) reported $6.9B in revenue over the twelve months to Sep 30, 2026, up 26.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BRO FY2025

FY2025 scale expanded through asset-heavy growth, while profits lagged revenue and cash generation remained strong.

FY2025 assets jumped 70.3% while goodwill jumped 89.3%, making the expansion look acquisition-heavy rather than primarily organic. Meanwhile, revenue rose 22.8% but net income rose only 6.1%, so the enlarged asset base had not yet translated proportionately into earnings.

Net margin fell 2.8 pp in FY2025, yet operating cash flow rose 23.5%, showing that accounting profitability weakened without a matching deterioration in cash collection. Free cash flow rose 26.6%, while capital expenditures were just 1.2% of revenue, indicating low reported reinvestment needs relative to sales.

Long-term debt rose 91.6% while debt-to-equity remained at 0.5x, because equity expanded alongside the asset base. A current ratio of 1.0x and liabilities equal to 58.2% of assets indicate limited near-term balance-sheet flexibility relative to the platform's enlarged scale.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 68 / 100
Financial Health Score 68/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Brown & Brown, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
93

Profitability ranks operating companies on their operating margin with gains on asset sales taken out, averaged over the last three fiscal years with the newest counting most, and in smaller part on how steady that margin has been. Brown & Brown, Inc. scores 93/100 on it among other operating companies.

Growth
79

Growth ranks operating companies on the yearly rate at which revenue compounded across the last three fiscal years (the last two where the earliest reports no revenue), counted in the currency each company reports in so that a move in the exchange rate is not read as growth. Brown & Brown, Inc. scores 79/100 on it among other operating companies.

Leverage
52

Brown & Brown, Inc. carried $0.55 of long-term debt for every $1 of shareholders' equity at the end of fiscal year 2025, a debt-to-equity ratio of 0.55. With no EBITDA figure for fiscal year 2025, Brown & Brown, Inc. is ranked on that ratio rather than on net debt against EBITDA, a lower ratio being the safer one, and scores 52/100 among other operating companies measured the same way.

Liquidity
21

Brown & Brown, Inc. held $1.04 of current assets for every $1 of current liabilities at the end of fiscal year 2025, a current ratio of 1.04. Liquidity ranks operating companies on that ratio, and Brown & Brown, Inc. scores 21/100 among other operating companies.

Cash Flow
89

Cash Flow ranks operating companies on their free cash flow margin, which is operating cash flow less capital spending as a share of revenue, averaged over the last three fiscal years with the newest weighted most. Brown & Brown, Inc. scores 89/100 on it among other operating companies.

Returns
73

Returns ranks operating companies on their return on capital employed, which is operating income against total assets less current liabilities, averaged over three fiscal years with the newest weighted most, and in smaller part on how steady that return has been. Brown & Brown, Inc. scores 73/100 on it among other operating companies.

Piotroski F-Score Partial
3/8

Brown & Brown, Inc. passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), the one computable operating efficiency signal (asset turnover improving) does not pass.

Earnings Quality Cash-Backed
1.38x

For every $1 of reported earnings, Brown & Brown, Inc. generates $1.38 in operating cash flow ($1.4B OCF vs $1.1B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$1.7B
YoY+7.4%
QoQ+2.9%
5Y CAGR+17.5%
10Y CAGR+14.1%

Brown & Brown, Inc. generated $1.7B in revenue in Q3 2026. This represents an increase of 7.4% from the same quarter a year earlier. Against the prior quarter it is up 2.9%.

Net Income
$240.0M
YoY+5.7%
QoQ-16.7%
5Y CAGR+10.4%
10Y CAGR+12.9%

Brown & Brown, Inc. reported $240.0M in net income in Q3 2026. This represents an increase of 5.7% from the same quarter a year earlier. Against the prior quarter it is down 16.7%.

EPS (Diluted)
$0.67
YoY-1.5%
QoQ-20.2%
5Y CAGR+5.2%

Brown & Brown, Inc. earned $0.67 per diluted share (EPS) in Q3 2026. This represents a decrease of 1.5% from the same quarter a year earlier. Against the prior quarter it is down 20.2%.

EBITDA

Not reported for Q3 2026.

Cash & Balance Sheet

Free Cash Flow
$493.0M
YoY+9.1%
QoQ+49.8%
5Y CAGR+15.6%
10Y CAGR+14.8%

Brown & Brown, Inc. generated $493.0M in free cash flow in Q3 2026, representing cash available after capex. This represents an increase of 9.1% from the same quarter a year earlier. Against the prior quarter it is up 49.8%.

Cash & Debt
$1.1B
YoY-7.6%
QoQ+19.7%
5Y CAGR+7.0%
10Y CAGR+8.4%

Brown & Brown, Inc. held $1.1B in cash against $7.3B in long-term debt as of Q3 2026.

Dividends Per Share
$0.17
YoY+10.0%
QoQ0.0%

Brown & Brown, Inc. paid $0.17 per share in dividends in Q3 2026. This represents an increase of 10.0% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding
332M
YoY-2.8%
QoQ-0.9%
5Y CAGR+3.3%

Brown & Brown, Inc. had 332M shares outstanding in Q3 2026. This represents a decrease of 2.8% from the same quarter a year earlier. Against the prior quarter it is down 0.9%.

Margins & Returns

Net Margin
13.9%
YoY-0.2pp
QoQ-3.3pp
5Y change-5.1pp
10Y change-1.6pp

Brown & Brown, Inc.'s net profit margin was 13.9% in Q3 2026, showing the share of revenue converted to profit. This is down 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.3 percentage points.

Return on Equity
1.9%
YoY+0.1pp
QoQ-0.4pp
5Y change-1.7pp
10Y change-1.2pp

Brown & Brown, Inc.'s quarterly ROE was 1.9% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 0.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.4 percentage points.

Gross Margin

Not reported for Q3 2026.

Operating Margin

Not reported for Q3 2026.

Capital Allocation

Share Buybacks
$250.0M
YoYn/m
QoQ0.0%

Brown & Brown, Inc. spent $250.0M on share buybacks in Q3 2026, returning capital to shareholders by reducing shares outstanding. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. It is unchanged from the prior quarter.

Capital Expenditures
$39.0M
YoY+143.8%
QoQ+129.4%
5Y CAGR+32.6%
10Y CAGR+25.0%

Brown & Brown, Inc. invested $39.0M in capex in Q3 2026, funding long-term assets and infrastructure. This represents an increase of 143.8% from the same quarter a year earlier. Against the prior quarter it is up 129.4%.

R&D Spending

Not reported for Q3 2026.

BRO Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BRO quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$1.7B+7.4%$1.7B+30.4%$1.9B+35.4%$1.6B+35.8%$1.6B+35.4%$1.3B+9.1%$1.4B+11.6%$1.2B+15.3%
Interest Expense$100.0M0.0%$100.0M+96.1%$99.0M+115.2%$100.0M+117.4%$100.0M+100.0%$51.0M+4.1%$46.0M-4.2%$46.0M-3.2%
Income Tax$79.0M-3.7%$94.0M+22.1%$106.0M+14.0%$52.0M-20.0%$82.0M+5.1%$77.0M-11.5%$93.0M+31.0%$65.0M-25.3%
Net Income$240.0M+5.7%$288.0M+24.7%$426.0M+28.7%$265.0M+26.8%$227.0M-3.0%$231.0M-10.1%$331.0M+13.0%$209.0M-22.3%
EPS (Basic)$0.73+7.4%$0.86+8.9%$1.27+9.5%$0.78$0.68-17.1%$0.79-12.2%$1.16+12.6%$0.73-23.2%
EPS (Diluted)$0.67-1.5%$0.84+7.7%$1.06-7.8%$0.59$0.68-16.0%$0.78-13.3%$1.15+12.7%$0.73-22.3%
Diluted Shares (Avg)330M-0.6%334M+14.0%337M+18.2%N/A332M+16.9%293M+3.5%285M+0.7%N/A

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA.

BRO Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BRO quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$29.4B+0.3%$29.9B+16.6%$29.7B+77.2%$30.0B+70.3%$29.4B+67.5%$25.6B+60.8%$16.8B+13.2%$17.6B+18.3%
Current Assets$8.3B+1.4%$8.7B-39.8%$8.5B+42.9%$8.6B+24.4%$8.1B+8.9%$14.4B+137.2%$5.9B+18.2%$6.9B+35.0%
Cash & Equivalents$1.1B-7.6%$918.0M-89.7%$1.0B+49.9%$1.1B+59.9%$1.2B+24.3%$8.9B+703.3%$669.0M+15.1%$675.0M-3.6%
Short-Term Investments$0n/m$0n/m$0n/m$0-100.0%$0-100.0%$0-100.0%$0-100.0%$10.0M-9.1%
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0
Goodwill$15.2B+2.0%$15.1B+81.1%$15.1B+85.9%$15.1B+89.3%$14.9B+96.5%$8.4B+12.6%$8.1B+9.8%$8.0B+8.6%
Total Liabilities$16.9B-0.6%$17.3B+23.2%$17.1B+72.2%$17.4B+55.9%$17.0B+53.4%$14.0B+41.6%$9.9B+10.1%$11.2B+20.3%
Current Liabilities$7.2B+5.0%$7.7B+46.7%$8.3B+68.7%$8.3B+31.4%$6.9B+5.6%$5.3B-2.5%$4.9B+1.0%$6.3B+27.4%
Non-Current Liabilities$9.6B-4.4%$9.6B+9.2%$8.8B+75.6%$9.2B+87.6%$10.1B+122.2%$8.8B+94.1%$5.0B+20.8%$4.9B+12.2%
Long-Term Debt$7.3B-4.0%$7.3B-1.7%$6.6B+76.5%$6.9B+91.6%$7.7B+127.3%$7.5B+120.3%$3.7B+24.0%$3.6B+11.5%
Total Equity$12.6B+1.6%$12.6B+8.5%$12.6B+84.6%$12.5B+95.4%$12.4B+91.6%$11.6B+92.4%$6.8B+18.1%$6.4B+15.1%
Retained Earnings$7.8B+14.6%$7.6B+14.9%$7.4B+14.7%$7.0B+14.1%$6.8B+13.8%$6.6B+14.6%$6.4B+15.7%$6.1B+15.9%

Not reported in any period shown, so not listed: Inventory, Accounts Receivable.

BRO Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BRO quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow$532.0M+13.7%$346.0M+6.5%$262.0M+23.0%$444.0M+23.0%$468.0M+6.4%$325.0M-9.7%$213.0M+1538.5%$361.0M+18.0%
Depreciation & Amortization$18.0M+28.6%$18.0M+63.6%$17.0M+54.5%$18.0M+63.6%$14.0M+27.3%$11.0M0.0%$11.0M0.0%$11.0M+10.0%
Stock-Based CompensationN/AN/A$26.0M-10.3%N/AN/AN/A$29.0M0.0%N/A
Capital Expenditures$39.0M+143.8%$17.0M+13.3%$21.0M+23.5%$20.0M0.0%$16.0M-30.4%$15.0M-42.3%$17.0M+30.8%$20.0M-35.5%
Free Cash Flow$493.0M+9.1%$329.0M+6.1%$241.0M+23.0%$424.0M+24.3%$452.0M+8.4%$310.0M-7.2%$196.0Mn/m$341.0M+24.0%
Investing Cash Flow-$54.0Mn/m-$33.0Mn/m-$38.0Mn/m-$213.0Mn/m-$7.5Bn/m-$108.0M-1081.8%-$79.0Mn/m-$779.0Mn/m
Financing Cash Flow-$463.0Mn/m-$172.0M-102.1%-$354.0Mn/m-$138.0M-149.8%-$130.0Mn/m$8.2B+1755.0%-$218.0Mn/m$277.0M+214.8%
Dividends Paid$57.0M+11.8%$55.0M+27.9%$57.0M+32.6%$56.0M+30.2%$51.0M+41.7%$43.0M+16.2%$43.0M+13.2%$43.0M+16.2%
Share Buybacks$250.0Mn/m$250.0Mn/m$250.0Mn/m$100.0M$0$0$0N/A

BRO Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BRO quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Net Margin13.9%-0.2pp17.2%-0.8pp22.4%-1.2pp16.5%-1.2pp14.1%-5.6pp18.0%-3.8pp23.6%+0.3pp17.7%-8.5pp
Return on Equity1.9%+0.1pp2.3%+0.3pp3.4%-1.5pp2.1%-1.1pp1.8%-1.8pp2.0%-2.3pp4.9%-0.2pp3.3%-1.6pp
Return on Assets0.8%0.0pp1.0%+0.1pp1.4%-0.5pp0.9%-0.3pp0.8%-0.6pp0.9%-0.7pp2.0%0.0pp1.2%-0.6pp
Current Ratio1.140.0x1.13-1.6x1.02-0.2x1.04-0.1x1.180.0x2.75+1.6x1.20+0.2x1.10+0.1x
Debt-to-Equity0.580.0x0.58-0.1x0.520.0x0.550.0x0.62+0.1x0.64+0.1x0.550.0x0.560.0x
Liabilities-to-Equity1.340.0x1.38+0.2x1.36-0.1x1.39-0.4x1.37-0.3x1.21-0.4x1.46-0.1x1.74+0.1x
Asset Turnover0.060.0x0.060.0x0.060.0x0.050.0x0.050.0x0.050.0x0.080.0x0.070.0x
FCF Margin28.6%+0.4pp19.6%-4.5pp12.7%-1.3pp26.4%-2.5pp28.1%-7.0pp24.1%-4.2pp14.0%+14.0pp28.8%+2.0pp

Not reported in any period shown, so not listed: Gross Margin, Operating Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Brown & Brown, Inc. BRO FY2025 $5.9B $1.1B 17.9% $24.2B 68/100
Willis Towers Watson Public Limited Company WTW FY2025 $9.7B $1.6B 16.5% $30.5B 55/100
Erie Indemnity Co ERIE FY2025 $4.1B $559.3M 13.8% $14.2B 67/100
Arthur J. Gallagher & Co. AJG FY2025 $13.9B $1.5B 10.7% $71.6B 63/100
Ryan Specialty Holdings, Inc. RYAN FY2025 $3.1B $63.4M 2.1% $11.8B 60/100
Aon plc AON FY2025 $17.2B $3.7B 21.5% $70.7B 62/100

Frequently Asked Questions

Brown & Brown, Inc. (BRO) reported $5.9B in total revenue for fiscal year 2025. This represents a 22.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Brown & Brown, Inc. (BRO) revenue grew by 22.8% year-over-year, from $4.8B to $5.9B in fiscal year 2025.

Yes, Brown & Brown, Inc. (BRO) reported a net income of $1.2B over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net income of $1.1B, with a net profit margin of 17.9%.

Brown & Brown, Inc. (BRO) reported diluted earnings per share of $3.16 for fiscal year 2025. This represents a -8.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, Brown & Brown, Inc. (BRO) had $1.1B in cash and equivalents against $6.9B in long-term debt.

Brown & Brown, Inc. (BRO) had a net profit margin of 17.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Brown & Brown, Inc. (BRO) paid $0.62 per share in dividends during fiscal year 2025.

Brown & Brown, Inc. (BRO) has a return on equity of 8.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Brown & Brown, Inc. (BRO) generated $1.4B in free cash flow during fiscal year 2025. This represents a 26.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Brown & Brown, Inc. (BRO) generated $1.4B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Brown & Brown, Inc. (BRO) had $30.0B in total assets as of fiscal year 2025, including both current and long-term assets.

Brown & Brown, Inc. (BRO) invested $68.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Brown & Brown, Inc. (BRO) spent $100.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Brown & Brown, Inc. (BRO) had 340M shares outstanding as of fiscal year 2025.

Brown & Brown, Inc. (BRO) had a current ratio of 1.04 as of fiscal year 2025, which is considered adequate.

Brown & Brown, Inc. (BRO) had a debt-to-equity ratio of 0.55 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

Brown & Brown, Inc. (BRO) had a liabilities-to-equity ratio of 1.39 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

Brown & Brown, Inc. (BRO) had a return on assets of 3.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Brown & Brown, Inc. (BRO) trades at 19.9x earnings, its market capitalization divided by $1.2B net income, trailing 12 months to September 30, 2026. The market capitalization is $24.2B as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Brown & Brown, Inc. (BRO) trades at 3.5x sales, its market capitalization divided by $6.9B revenue, trailing 12 months to September 30, 2026. The market capitalization is $24.2B as of Nov 20, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Brown & Brown, Inc. (BRO) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Brown & Brown, Inc. (BRO) has an earnings quality ratio of 1.38x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Brown & Brown, Inc. (BRO) scores 68 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top